Meeting Quality Measures and Improving Outcomes in Heart Failure Patients With Comorbidities: Where Do New Therapies Fit? Describe the interrelationships of pathophysiology in heart failure (HF) and metabolic syndrome.
Assess how current HF therapies can be used synergistically in the treatment of patients with comorbid metabolic syndrome.
Evaluate the efficacy and safety of newly approved therapies for treating patients with HF and comorbid metabolic syndrome.
1.0 Free Contact Hours for Nurse Practitioners which includes 1.0 Hours of Pharmacology
Expires 12/16/17


Educational funding donation provided by Amgen and an educational grant from Novartis Pharmaceuticals Corporation.